Novoheart Showcase at Annual Safety Pharmacology Society Meeting
The SPS Annual Meeting, held between Sep 30 to Oct 3, was highly rewarding for Novoheart: an industry conference attended by many decision-makers in the safety pharmacology space, both from pharma and the US Food & Drug Administration (FDA), our latest technologies were widely showcased in oral presentations by CSO Dr. Kevin Costa, an array of scientific posters and a brand new modular bioreactor display at our exhibition booth, which received enthusiastic feedback from the attendees.
We were able to arrange multiple on-site meetings between our management team and industry executives to discuss partnerships and collaborations, with several contracts in negotiation and numerous additional leads for follow up.

Subscribe To Our Newsletter

Fill out the following to subscribe and start receiving updates from us!